Andrew M. Kaunitz M.D., FACOG Professor & Associate Chair, Department of Obstetrics and Gynecology; Medical Director, UF Health Women's Specialists - Emerson Department: Department of Obstetrics and Gynecology Business Phone: (904) 244-3109 Business Email: andrew.kaunitz@jax.ufl.edu Appointments and Locations Board Certifications Obstetrics and Gynecology Show More Clinical Profile Specialties Obstetrics and Gynecology Interests Clinical Special Interests: Contraception and menopausal medicine; general gynecologyResearch Special Interests: Contraception; menopausal medicine Show More Publications 2024Hormonal Medications for Genitourinary Syndrome of Menopause.Clinical obstetrics and gynecology.67(1):68-78[DOI] 10.1097/GRF.0000000000000835.[PMID] 38032827.1 citations·PubMed·Publisher's Site2024Methods for the induction of labor: efficacy and safety.American journal of obstetrics and gynecology.230(3S):S669-S695[DOI] 10.1016/j.ajog.2023.02.009.[PMID] 38462252.PubMed·Publisher's Site2024Outpatient cervical ripening and labor induction with low-dose vaginal misoprostol reduces the interval to delivery: a systematic review and network meta-analysis.American journal of obstetrics and gynecology.230(3S):S716-S728.e61[DOI] 10.1016/j.ajog.2022.09.043.[PMID] 38462254.PubMed·Publisher's Site2024Single-balloon catheter with concomitant vaginal misoprostol is the most effective strategy for labor induction: a meta-review with network meta-analysis.American journal of obstetrics and gynecology.230(3S):S696-S715[DOI] 10.1016/j.ajog.2022.01.005.[PMID] 38462253.PubMed·Publisher's Site2024Water birth: a systematic review and meta-analysis of maternal and neonatal outcomes.American journal of obstetrics and gynecology.230(3S):S961-S979.e33[DOI] 10.1016/j.ajog.2023.08.034.[PMID] 38462266.PubMed·Publisher's Site2023Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review.Obstetrics and gynecology.142(4):967-977[DOI] 10.1097/AOG.0000000000005338.[PMID] 37734095.PubMed·Publisher's Site2023Intrapartum amnioinfusion reduces meconium aspiration syndrome and improves neonatal outcomes in patients with meconium-stained fluid: a systematic review and meta-analysis.American journal of obstetrics and gynecology.228(5S):S1179-S1191.e19[DOI] 10.1016/j.ajog.2022.07.047.[PMID] 37164492.3 citations·PubMed·Publisher's Site2023Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms.The Journal of clinical endocrinology and metabolism.108(11):e1448-e1449[DOI] 10.1210/clinem/dgad209.[PMID] 37097747.1 citations·PubMed·Publisher's Site2023Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?Circulation.147(7):597-610[DOI] 10.1161/CIRCULATIONAHA.122.061559.[PMID] 36780393.7 citations·PubMed·Publisher's Site2022Incorporating Black women's perspectives into long-acting reversible contraception implementation.F&S reports.3(2 Suppl):80-90[DOI] 10.1016/j.xfre.2022.02.005.[PMID] 35937447.PubMed·Publisher's Site2022Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women.Contraception.116():29-36[DOI] 10.1016/j.contraception.2022.07.010.[PMID] 35921872.3 citations·PubMed·Publisher's Site2022Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials.Contraception.116():37-43[DOI] 10.1016/j.contraception.2022.07.009.[PMID] 35921870.5 citations·PubMed·Publisher's Site2022Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer.Menopause (New York, N.Y.).29(9):1001-1004[DOI] 10.1097/GME.0000000000002057.[PMID] 35998670.PubMed·Publisher's Site2022Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.Contraception.116():44-50[DOI] 10.1016/j.contraception.2022.10.004.[PMID] 36257374.4 citations·PubMed·Publisher's Site2021A Low 50-gram, 1-hour Glucose Challenge Test Value Predicts Neonatal Birth Weight Less than the 10th Percentile: A Systematic Review and Meta-Analysis.American journal of perinatology.38(8):841-847[DOI] 10.1055/s-0039-3402749.[PMID] 31986539.1 citations·PubMed·Publisher's Site2021Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative.Menopause (New York, N.Y.).28(6):610-618[DOI] 10.1097/GME.0000000000001753.[PMID] 33950030.9 citations·PubMed·Publisher's Site2021Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results.Contraception.103(3):137-143[DOI] 10.1016/j.contraception.2020.11.011.[PMID] 33259782.11 citations·PubMed·Publisher's Site2021Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results.Contraception.104(3):222-228[DOI] 10.1016/j.contraception.2021.05.002.[PMID] 34000251.25 citations·PubMed·Publisher's Site2021Genital powder use and risk of uterine cancer: A pooled analysis of prospective studies.International journal of cancer.148(11):2692-2701[DOI] 10.1002/ijc.33470.[PMID] 33433939.3 citations·PubMed·Publisher's Site2021Hormonal Contraception: Systemic Estrogen and Progestin Preparations.Clinical obstetrics and gynecology.64(4):721-738[DOI] 10.1097/GRF.0000000000000634.[PMID] 34668886.2 citations·PubMed·Publisher's Site2021Maintaining cognitive function in surgically menopausal women: the importance of estrogen.Menopause (New York, N.Y.).28(4):349-351[DOI] 10.1097/GME.0000000000001743.[PMID] 33570874.PubMed·Publisher's Site2021Pregnancy outcomes associated with an abnormal 50-g glucose screen during pregnancy: a systematic review and Meta-analysis.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.34(24):4132-4140[DOI] 10.1080/14767058.2019.1706473.[PMID] 31893960.4 citations·PubMed·Publisher's Site2021Risks of Testosterone for Postmenopausal Women.Endocrinology and metabolism clinics of North America.50(1):139-150[DOI] 10.1016/j.ecl.2020.10.007.[PMID] 33518182.0 citations·PubMed·Publisher's Site2021Segesterone acetate serum levels with a regression model of continuous use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system.Contraception.104(3):229-234[DOI] 10.1016/j.contraception.2021.03.024.[PMID] 33785318.1 citations·PubMed·Publisher's Site2021Treatment of Women After Bilateral Salpingo-oophorectomy Performed Prior to Natural Menopause.JAMA.326(14):1429-1430[DOI] 10.1001/jama.2021.3305.[PMID] 34636868.14 citations·PubMed·Publisher's Site202017β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial.Menopause (New York, N.Y.).27(12):1382-1387[DOI] 10.1097/GME.0000000000001615.[PMID] 32740481.2 citations·PubMed·Publisher's Site2020Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.JAMA.323(1):49-59[DOI] 10.1001/jama.2019.20079.[PMID] 31910280.34 citations·PubMed·Publisher's Site2020Best Practices for Counseling Adolescents about the Etonogestrel Implant.Journal of pediatric and adolescent gynecology.33(5):448-454[DOI] 10.1016/j.jpag.2020.06.022.[PMID] 32621879.14 citations·PubMed·Publisher's Site2020Does umbilical cord milking increase the risk of severe intraventricular hemorrhage in extreme preterm neonates? A multitreatment comparison.American journal of obstetrics and gynecology.223(4):590-592[DOI] 10.1016/j.ajog.2020.06.043.[PMID] 32593537.2 citations·PubMed·Publisher's Site2020Hormone therapy and sarcopenia: implications for the prevention of frailty as women age.Menopause (New York, N.Y.).27(5):496-497[DOI] 10.1097/GME.0000000000001541.[PMID] 32187132.PubMed·Publisher's Site2020In Reply.Menopause (New York, N.Y.).27(9):1097-1098[DOI] 10.1097/GME.0000000000001625.[PMID] 32852466.PubMed·Publisher's Site2020Intercepting Endometrial Cancer: Opportunities to Expand Access Using New Technology.Cancer prevention research (Philadelphia, Pa.).13(7):563-568[DOI] 10.1158/1940-6207.CAPR-19-0556.[PMID] 32047026.6 citations·PubMed·Publisher's Site2020Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.JAMA internal medicine.180(9):1232-1240[DOI] 10.1001/jamainternmed.2020.2986.[PMID] 32730575.35 citations·PubMed·Publisher's Site2020Surgical menopause: health implications and hormonal management.Menopause (New York, N.Y.).28(1):1-3[DOI] 10.1097/GME.0000000000001680.[PMID] 33048864.7 citations·PubMed·Publisher's Site2020The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy.Menopause (New York, N.Y.).27(11):1199-1201[DOI] 10.1097/GME.0000000000001672.[PMID] 33110032.5 citations·PubMed·Publisher's Site2020The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.Menopause (New York, N.Y.).27(8):918-928[DOI] 10.1097/GME.0000000000001553.[PMID] 32345788.18 citations·PubMed·Publisher's Site2020TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial.Menopause (New York, N.Y.).27(11):1236-1241[DOI] 10.1097/GME.0000000000001602.[PMID] 33110039.5 citations·PubMed·Publisher's Site2019Abnormal Uterine Bleeding in Reproductive-Age Women.JAMA.321(21):2126-2127[DOI] 10.1001/jama.2019.5248.[PMID] 31070673.9 citations·PubMed·Publisher's Site2019Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study.American journal of epidemiology.188(2):261-273[DOI] 10.1093/aje/kwy249.[PMID] 30407487.12 citations·PubMed·Publisher's Site2019Breast Cancer and the Obstetrician-Gynecologist: A Focus on Screening, Risk Assessment and Treatment of Survivors With Genitourinary Syndrome of Menopause.Clinical obstetrics and gynecology.62(4):634-643[DOI] 10.1097/GRF.0000000000000479.[PMID] 31259841.3 citations·PubMed·Publisher's Site2019Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use?Contraception.100(4):264-268[DOI] 10.1016/j.contraception.2019.05.017.[PMID] 31176688.10 citations·PubMed·Publisher's Site2019Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia.Menopause (New York, N.Y.).26(11):1259-1264[DOI] 10.1097/GME.0000000000001394.[PMID] 31688572.5 citations·PubMed·Publisher's Site2019Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices.Menopause (New York, N.Y.).26(9):994-1001[DOI] 10.1097/GME.0000000000001350.[PMID] 31453961.13 citations·PubMed·Publisher's Site2019Global Consensus Position Statement on the Use of Testosterone Therapy for Women.Climacteric : the journal of the International Menopause Society.22(5):429-434[DOI] 10.1080/13697137.2019.1637079.[PMID] 31474158.32 citations·PubMed·Publisher's Site2019Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The journal of sexual medicine.16(9):1331-1337[DOI] 10.1016/j.jsxm.2019.07.012.[PMID] 31488288.16 citations·PubMed·Publisher's Site2019Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The Journal of clinical endocrinology and metabolism.104(10):4660-4666[DOI] 10.1210/jc.2019-01603.[PMID] 31498871.104 citations·PubMed·Publisher's Site2019Global Consensus Position Statement on the use of Testosterone Therapy for Women.Maturitas.128():89-93[DOI] 10.1016/j.maturitas.2019.07.001.[PMID] 31484631.9 citations·PubMed·Publisher's Site2019Management of Menopause and the Role For Hormone Therapy.Clinical obstetrics and gynecology.62(4):677-686[DOI] 10.1097/GRF.0000000000000487.[PMID] 31503029.4 citations·PubMed·Publisher's Site2019Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.Annals of internal medicine.171(6):406-414[DOI] 10.7326/M19-0274.[PMID] 31499528.31 citations·PubMed·Publisher's Site2019Menopause Management Knowledge in Postgraduate Family Medicine, Internal Medicine, and Obstetrics and Gynecology Residents: A Cross-Sectional Survey.Mayo Clinic proceedings.94(2):242-253[DOI] 10.1016/j.mayocp.2018.08.033.[PMID] 30711122.29 citations·PubMed·Publisher's Site2019Metabolic and cardiovascular effects of TX-001HR in menopausal women with vasomotor symptoms.Climacteric : the journal of the International Menopause Society.22(6):610-616[DOI] 10.1080/13697137.2019.1640197.[PMID] 31364889.12 citations·PubMed·Publisher's Site2019Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms.Menopause (New York, N.Y.).26(5):506-512[DOI] 10.1097/GME.0000000000001271.[PMID] 30489424.15 citations·PubMed·Publisher's Site2019Povidone-iodine 1% is the most effective vaginal antiseptic for preventing post-cesarean endometritis: a systematic review and network meta-analysis.American journal of obstetrics and gynecology.221(3):261.e1-261.e20[DOI] 10.1016/j.ajog.2019.04.002.[PMID] 30954518.18 citations·PubMed·Publisher's Site2019Reproductive health care across the lifecourse of the female cancer patient.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.27(1):23-32[DOI] 10.1007/s00520-018-4360-5.[PMID] 30051202.6 citations·PubMed·Publisher's Site2019Vaginal estrogen: Underprescribed treatment for an underdiagnosed condition of menopausal women.Maturitas.121():83-85[DOI] 10.1016/j.maturitas.2018.08.001.[PMID] 30098845.PubMed·Publisher's Site2019Women harmed by vaginal laser for treatment of GSM-the latest casualties of fear and confusion surrounding hormone therapy.Menopause (New York, N.Y.).26(4):338-340[DOI] 10.1097/GME.0000000000001313.[PMID] 30789455.7 citations·PubMed·Publisher's Site2018A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial.Obstetrics and gynecology.132(1):161-170[DOI] 10.1097/AOG.0000000000002645.[PMID] 29889748.41 citations·PubMed·Publisher's Site2018Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.Menopause (New York, N.Y.).25(1):11-20[DOI] 10.1097/GME.0000000000000956.[PMID] 28816933.131 citations·PubMed·Publisher's Site2018Concern about US Preventive Services Task Force recommendation on hormone therapy for the primary prevention of chronic conditions in postmenopausal women.Menopause (New York, N.Y.).25(5):476-[DOI] 10.1097/GME.0000000000001100.[PMID] 29658911.3 citations·PubMed·Publisher's Site2018Contraception for midlife women: a review.Menopause (New York, N.Y.).25(7):817-827[DOI] 10.1097/GME.0000000000001073.[PMID] 29462093.8 citations·PubMed·Publisher's Site2018Extended Use of Systemic Menopausal Hormone Therapy.Clinical obstetrics and gynecology.61(3):517-522[DOI] 10.1097/GRF.0000000000000382.[PMID] 29781874.3 citations·PubMed·Publisher's Site2018Foreword: Managing Menopause by Combining Evidence With Clinical Judgment.Clinical obstetrics and gynecology.61(3):417-418[DOI] 10.1097/GRF.0000000000000387.[PMID] 29889666.PubMed·Publisher's Site2018Hormonal contraception and risk of breast cancer: a closer look.Menopause (New York, N.Y.).25(5):477-479[DOI] 10.1097/GME.0000000000001101.[PMID] 29557848.PubMed·Publisher's Site2018Improvement in sleep outcomes with a 17β-estradiol-progesterone oral capsule (TX-001HR) for postmenopausal women.Menopause (New York, N.Y.).26(6):622-628[DOI] 10.1097/GME.0000000000001278.[PMID] 30586005.17 citations·PubMed·Publisher's Site2018Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.Menopause (New York, N.Y.).25(6):596-608[DOI] 10.1097/GME.0000000000001121.[PMID] 29762200.112 citations·PubMed·Publisher's Site2018Not time to abandon use of local vaginal hormone therapies.Menopause (New York, N.Y.).25(8):855-858[DOI] 10.1097/GME.0000000000001142.[PMID] 29894370.6 citations·PubMed·Publisher's Site2018Screening mammography for average-risk women.Menopause (New York, N.Y.).25(3):343-345[DOI] 10.1097/GME.0000000000001026.[PMID] 29257034.PubMed·Publisher's Site2018Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women.Journal of thrombosis and haemostasis : JTH.16(5):886-892[DOI] 10.1111/jth.13993.[PMID] 29504242.2 citations·PubMed·Publisher's Site2017A systematic review and meta-analysis of hypocalciuria in pre-eclampsia.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.138(1):3-11[DOI] 10.1002/ijgo.12165.[PMID] 28369876.7 citations·PubMed·Publisher's Site2017Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study.Menopause (New York, N.Y.).24(10):1145-1153[DOI] 10.1097/GME.0000000000000899.[PMID] 28697036.19 citations·PubMed·Publisher's Site2017Contraceptive Considerations for Women with Gastrointestinal Disorders.Digestive diseases and sciences.62(1):54-63[DOI] 10.1007/s10620-016-4383-z.[PMID] 27885460.2 citations·PubMed·Publisher's Site2017Long-acting reversible contraception: an important solution to reduce unintended pregnancy.American journal of obstetrics and gynecology.216(5):539-[DOI] 10.1016/j.ajog.2017.03.004.[PMID] 28284931.PubMed·Publisher's Site2017Menopausal hormone therapy and national time trends in mortality: cautions regarding causal inference.Menopause (New York, N.Y.).24(8):874-876[DOI] 10.1097/GME.0000000000000886.[PMID] 28486245.2 citations·PubMed·Publisher's Site2017The 2017 Hormone Therapy Position Statement of the North American Menopause SocietyMenopause-the Journal of the North American Menopause Society.24(7):728-753[DOI] 10.1097/GME.0000000000000921.[PMID] .PubMed·Publisher's Site2017The cross-sectional association between vasomotor symptoms and hemostatic parameter levels in postmenopausal women.Menopause (New York, N.Y.).24(4):360-370[DOI] 10.1097/GME.0000000000000777.[PMID] 27922933.3 citations·PubMed·Publisher's Site2017The US etonogestrel implant mandatory clinical training and active monitoring programs: 6-year experience.Contraception.95(2):205-210[DOI] 10.1016/j.contraception.2016.07.012.[PMID] 27452317.22 citations·PubMed·Publisher's Site2017Vaginal estrogen in the treatment of genitourinary syndrome of menopause and risk of endometrial cancer: an assessment of recent studies provides reassurance.Menopause (New York, N.Y.).24(12):1329-1332[DOI] 10.1097/GME.0000000000000996.[PMID] 29040220.11 citations·PubMed·Publisher's Site2016An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.Journal of minimally invasive gynecology.23(3):303-8[DOI] 10.1016/j.jmig.2015.12.012.[PMID] 26773577.13 citations·PubMed·Publisher's Site2016Clinical trials of new treatments for menopausal conditions: paying attention to race.Menopause (New York, N.Y.).23(6):589-90[DOI] 10.1097/GME.0000000000000637.[PMID] 27070806.PubMed·Publisher's Site2016Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.21(2):106-15[DOI] 10.3109/13625187.2015.1107894.[PMID] 26572318.28 citations·PubMed·Publisher's Site2016In Reply.Obstetrics and gynecology.127(5):966-967[DOI] 10.1097/AOG.0000000000001416.[PMID] 27101114.PubMed·Publisher's Site2016Menopause Management--Getting Clinical Care Back on Track.The New England journal of medicine.374(9):803-6[DOI] 10.1056/NEJMp1514242.[PMID] 26962899.119 citations·PubMed·Publisher's Site2016Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysis.American journal of obstetrics and gynecology.215(3):287-97[DOI] 10.1016/j.ajog.2016.04.040.[PMID] 27133007.50 citations·PubMed·Publisher's Site2016Stopping systemic menopausal hormone therapy: Why, when and how.Maturitas.89():3-4[DOI] 10.1016/j.maturitas.2016.03.020.[PMID] 27180152.2 citations·PubMed·Publisher's Site2016U.S. Food and Drug Administration's Guidance Regarding Morcellation of Leiomyomas: Well-Intentioned, But Is It Harmful for Women?Obstetrics and gynecology.127(1):18-22[DOI] 10.1097/AOG.0000000000001157.[PMID] 26646134.42 citations·PubMed·Publisher's Site2016Use of systemic hormone therapy in BRCA mutation carriers.Menopause (New York, N.Y.).23(9):1026-7[DOI] 10.1097/GME.0000000000000724.[PMID] 27504919.21 citations·PubMed·Publisher's Site2015Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society.Menopause (New York, N.Y.).22(3):247-53[DOI] 10.1097/GME.0000000000000373.[PMID] 25314150.48 citations·PubMed·Publisher's Site2015Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis.American journal of obstetrics and gynecology.212(4):505.e1-13[DOI] 10.1016/j.ajog.2014.10.1091.[PMID] 25448524.53 citations·PubMed·Publisher's Site2015Balancing the efficacy and safety of misoprostol: a meta-analysis comparing 25 versus 50 micrograms of intravaginal misoprostol for the induction of labour.BJOG : an international journal of obstetrics and gynaecology.122(4):468-76[DOI] 10.1111/1471-0528.12935.[PMID] 24989790.24 citations·PubMed·Publisher's Site2015Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.JAMA oncology.1(3):296-305[DOI] 10.1001/jamaoncol.2015.0494.[PMID] 26181174.142 citations·PubMed·Publisher's Site2015Compounded bioidentical hormone therapy: time for a reality check?Menopause (New York, N.Y.).22(9):919-20[DOI] 10.1097/GME.0000000000000484.[PMID] 26035149.1 citations·PubMed·Publisher's Site2015Does Cervical Ripening With Foley Catheters Increase Infectious Morbidity? a Systematic Review With Meta-AnalysisObstetrics and Gynecology.125(1):64S-[DOI] .[PMID] .PubMed·Publisher's Site2015Evaluation of a Transcervical Foley Catheter as a Source of Infection: A Systematic Review and Meta-analysis.Obstetrics and gynecology.126(3):539-551[DOI] 10.1097/AOG.0000000000001002.[PMID] 26244535.64 citations·PubMed·Publisher's Site2015Failure to treat menopausal symptoms: a disconnect between clinical practice and scientific data.Menopause (New York, N.Y.).22(7):687-8[DOI] 10.1097/GME.0000000000000457.[PMID] 25850357.2 citations·PubMed·Publisher's Site2015Management of Menopausal Symptoms.Obstetrics and gynecology.126(4):859-876[DOI] 10.1097/AOG.0000000000001058.[PMID] 26348174.102 citations·PubMed·Publisher's Site2015NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older.Menopause (New York, N.Y.).22(7):685-6[DOI] 10.1097/GME.0000000000000491.[PMID] 26035151.7 citations·PubMed·Publisher's Site2015New contraceptive patch wearability assessed by investigators and participants in a randomized phase 3 study.Contraception.91(3):211-6[DOI] 10.1016/j.contraception.2014.11.013.[PMID] 25586864.3 citations·PubMed·Publisher's Site2015Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system.Contraception.91(5):412-7[DOI] 10.1016/j.contraception.2015.01.021.[PMID] 25661510.13 citations·PubMed·Publisher's Site2015Reply: To PMID 25448524.American journal of obstetrics and gynecology.213(6):879-[DOI] 10.1016/j.ajog.2015.08.023.[PMID] 26283456.PubMed·Publisher's Site2015Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).Cancer causes & control : CCC.26(2):287-296[DOI] 10.1007/s10552-014-0510-3.[PMID] 25534916.38 citations·PubMed·Publisher's Site2015Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women.American journal of obstetrics and gynecology.212(3):318.e1-8[DOI] 10.1016/j.ajog.2014.09.014.[PMID] 25220709.9 citations·PubMed·Publisher's Site2015Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill.Contraception.91(3):204-10[DOI] 10.1016/j.contraception.2014.11.011.[PMID] 25582984.17 citations·PubMed·Publisher's Site2014Cervical and vaginal flora specimens are highly concordant with respect to bacterial vaginosis-associated organisms and commensal Lactobacillus species in women of reproductive age.Journal of clinical microbiology.52(8):3078-81[DOI] 10.1128/JCM.00795-14.[PMID] 24899020.18 citations·PubMed·Publisher's Site2014Comment on 'Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives': authors' response.The journal of family planning and reproductive health care.40(3):235-[DOI] 10.1136/jfprhc-2014-100925.[PMID] 24939488.2 citations·PubMed·Publisher's Site2014Comment on 'practical advice for avoidance of pain associated with insertion of intrauterine contraceptives': authors' response.The journal of family planning and reproductive health care.40(2):152-3[DOI] 10.1136/jfprhc-2014-100874.[PMID] 24648536.PubMed·Publisher's Site2014Comment On `Practical Advice for Avoidance of Pain Associated With Insertion of Intrauterine Contraceptives': Authors' ResponseJournal of Family Planning and Reproductive Health Care.40(2):152-U82[DOI] 10.1136/jfprhc-2013-100848.[PMID] 24648535.2 citations·PubMed·Publisher's Site2014Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.Menopause (New York, N.Y.).21(10):1082-90[DOI] 10.1097/GME.0000000000000210.[PMID] 24552977.16 citations·PubMed·Publisher's Site2014Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.Contraception.89(4):299-306[DOI] 10.1016/j.contraception.2014.01.013.[PMID] 24576794.14 citations·PubMed·Publisher's Site2014Extended duration use of menopausal hormone therapy.Menopause (New York, N.Y.).21(6):679-81[DOI] 10.1097/GME.0000000000000175.[PMID] 24398408.21 citations·PubMed·Publisher's Site2014Global fee prohibits postpartum provision of the most effective reversible contraceptives.Contraception.90(5):466-7[DOI] 10.1016/j.contraception.2014.08.005.[PMID] 25212061.37 citations·PubMed·Publisher's Site2014Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study.Menopause (New York, N.Y.).21(3):260-6[DOI] 10.1097/GME.0b013e31829a64f9.[PMID] 24045672.72 citations·PubMed·Publisher's Site2014In reply.Obstetrics and gynecology.123(5):1107-1108[DOI] 10.1097/AOG.0000000000000248.[PMID] 24785870.PubMed·Publisher's Site2014Injectable contraception: issues and opportunities.Contraception.89(5):331-4[DOI] 10.1016/j.contraception.2014.03.014.[PMID] 24767245.6 citations·PubMed·Publisher's Site2014Long-Term Issues in Hormone Therapy ManagementMenopause-the Journal of the North American Menopause Society.21(12):1322-[DOI] .[PMID] .PubMed·Publisher's Site2014Long-Term Safety of Unopposed Estrogen Used By Women Surviving Myocardial Infarction: 14-Year Follow-Up of the Esprit Randomised Controlled TrialBjog-An International Journal of Obstetrics and Gynaecology.121(6):705-5; discussion 705[DOI] 10.1111/1471-0528.12598.[PMID] 24533510.31 citations·PubMed·Publisher's Site2014Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.Obstetrics and gynecology.123(2 Pt 1):295-303[DOI] 10.1097/AOG.0000000000000095.[PMID] 24402597.17 citations·PubMed·Publisher's Site2014Paroxetine 7.5 Mg Reduces Daily Frequency and Severity of Vasomotor Symptoms (Vms) Associated With Menopause: Results From 2 Multicenter, Randomized, Double-Blind, Controlled Phase 3 StudiesJournal of Womens Health.23(4):17-[DOI] .[PMID] .PubMed·Publisher's Site2014Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives.The journal of family planning and reproductive health care.40(1):54-60[DOI] 10.1136/jfprhc-2013-100636.[PMID] 24076534.25 citations·PubMed·Publisher's Site2014The Association Between Vasomotor Symptoms and Hemostatic Factors in Postmenopausal WomenMenopause-the Journal of the North American Menopause Society.21(12):1332-1333[DOI] .[PMID] .PubMed·Publisher's Site2014The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis.American journal of obstetrics and gynecology.210(1):54.e1-54.e10[DOI] 10.1016/j.ajog.2013.09.004.[PMID] 24021995.57 citations·PubMed·Publisher's Site2014Why the product labeling for low-dose vaginal estrogen should be changed.Menopause (New York, N.Y.).21(9):911-6[DOI] 10.1097/GME.0000000000000316.[PMID] 25140698.60 citations·PubMed·Publisher's Site2013Bleeding Profile of a Novel Ascending-Dose, Extended-Regimen Ethinyl Estradiol/Levonorgestrel Combination Oral Contraceptive (Oc)Contraception.88():311-312[DOI] .[PMID] .PubMed·Publisher's Site2013Comment on journal review of 'Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture'.The journal of family planning and reproductive health care.39(4):306-[DOI] 10.1136/jfprhc-2013-100759.[PMID] 24062508.PubMed·Publisher's Site2013Contraception in women over 40 years of age.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.185(7):565-73[DOI] 10.1503/cmaj.121280.[PMID] 23460635.32 citations·PubMed·Publisher's Site2013Hormonal and intrauterine contraception for women aged 40 years and older.Women's health (London, England).9(5):421-4[DOI] 10.2217/whe.13.38.[PMID] 24007246.PubMed·Publisher's Site2013Impact On Body Weight and Sexual Function During Treatment of Vasomotor Symptoms (Vms) Due To Menopause With Low-Dose Mesylate Salt of Paroxetine (Ldmp)Menopause-the Journal of the North American Menopause Society.20(12):1320-[DOI] .[PMID] .PubMed·Publisher's Site2013Impact On Body Weight and Sexual Function During Treatment of Vasomotor Symptoms (Vms) Due To Menopause With Low-Dose Mesylate Salt of Paroxetine (Ldmp)Menopause-the Journal of the North American Menopause Society.20(12):1320-[DOI] .[PMID] .PubMed·Publisher's Site2013Is Uterine Leiomyomata Associated With Postmenopausal Bleeding? a Retrospective ReviewMenopause-the Journal of the North American Menopause Society.20(12):1334-[DOI] .[PMID] .PubMed·Publisher's Site2013Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.Obstetrics and gynecology.121(1):172-6[DOI] .[PMID] 23262943.61 citations·PubMed·Publisher's Site2013Low-Dose Mesylate Salt of Paroxetine (Ldmp) Reduced Daily Frequency and Severity of Vasomotor Symptoms (Vms) Due To MenopauseMenopause-the Journal of the North American Menopause Society.20(12):1340-1341[DOI] .[PMID] .PubMed·Publisher's Site2013Low-Dose Mesylate Salt of Paroxetine (Ldmp) Reduced Daily Frequency of Moderate Vasomotor Symptoms (Vms) and Severe Vms Due To MenopauseMenopause-the Journal of the North American Menopause Society.20(12):1340-[DOI] .[PMID] .PubMed·Publisher's Site2013Low-Dose Mesylate Salt of Paroxetine (Ldmp) Reduced Daily Frequency of Moderate Vasomotor Symptoms (Vms) and Severe Vms Due To MenopauseMenopause-the Journal of the North American Menopause Society.20(12):1340-[DOI] .[PMID] .PubMed·Publisher's Site2013Low-Dose Mesylate Salt of Paroxetine (Ldmp) Reduced Patient Burden of Menopausal Vasomotor SymptomsMenopause-the Journal of the North American Menopause Society.20(12):1348-[DOI] .[PMID] .PubMed·Publisher's Site2013Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.Menopause (New York, N.Y.).20(10):1027-35[DOI] 10.1097/GME.0b013e3182a66aa7.[PMID] 24045678.95 citations·PubMed·Publisher's Site2013Management of pain associated with the insertion of intrauterine contraceptives.Human reproduction update.19(4):419-27[DOI] 10.1093/humupd/dmt022.[PMID] 23670222.31 citations·PubMed·Publisher's Site2013Should new-onset arthralgia be considered a menopausal symptom?Menopause (New York, N.Y.).20(6):591-3[DOI] 10.1097/GME.0b013e31828a6a3d.[PMID] 23549444.2 citations·PubMed·Publisher's Site2013Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.The journal of family planning and reproductive health care.39(3):156-9[DOI] 10.1136/jfprhc-2013-100624.[PMID] 23585363.17 citations·PubMed·Publisher's Site2013Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.18(3):143-7[DOI] 10.3109/13625187.2013.792637.[PMID] 23578274.11 citations·PubMed·Publisher's Site2013The levonorgestrel intrauterine system: effective non-surgical treatment for heavy menstrual bleeding.Evidence-based medicine.18(6):e57-[DOI] 10.1136/eb-2013-101275.[PMID] 23635841.PubMed·Publisher's Site2013The protein-to-creatinine ratio for the prediction of significant proteinuria in patients at risk for preeclampsia: a meta-analysis.Annals of clinical and laboratory science.43(2):211-20[DOI] .[PMID] 23694798.15 citations·PubMed·Publisher's Site2013Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture.Obstetrics and gynecology.121(3):593-600[DOI] 10.1097/AOG.0b013e318283d1a1.[PMID] 23635623.41 citations·PubMed·Publisher's Site2012Disparity in menopausal hormone therapy use between women obstetrician gynecologists and women overall: are obstetrician gynecologists underserving their patients?Menopause (New York, N.Y.).19(10):1070-1[DOI] .[PMID] 22929036.3 citations·PubMed·Publisher's Site2012Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.Obstetrics and gynecology.119(5):989-99[DOI] 10.1097/AOG.0b013e318250c3a0.[PMID] 22525910.37 citations·PubMed·Publisher's Site2012Increased Compliance Independent of Patient Demographics With a Low-Dose Combination Contraceptive Patch (Ag200-15) Compared With a Low-Dose Combination Oral Contraceptive in a Phase 3 Clinical TrialContraception.86():314-[DOI] .[PMID] .PubMed·Publisher's Site2012Increased Compliance Independent of Patient Demographics With a Low-Dose Combination Contraceptive Patch (Ag200-15) Compared With a Low-Dose Combination Oral Contraceptive in a Phase 3 Clinical TrialContraception.86():314-[DOI] .[PMID] .PubMed·Publisher's Site2012Increased Compliance With a Low-Dose Combination Contraceptive Patch (Ag200-15) Compared With a Low-Dose Combination Oral Contraceptive (Coc) in a Phase 3 Clinical TrialContraception.86():178-[DOI] .[PMID] .PubMed·Publisher's Site2012Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.Contraception.86(5):452-7[DOI] 10.1016/j.contraception.2012.07.018.[PMID] 22959906.24 citations·PubMed·Publisher's Site2012Study had insufficient power to investigate safety.BMJ (Clinical research ed.).345():e8146; author reply e8164-[DOI] 10.1136/bmj.e8146.[PMID] 23208257.4 citations·PubMed·Publisher's Site2012The 2010 North American Menopause Society Position Statement On Hormone Therapy Goes Beyond the Available Evidence ResponseMenopause-the Journal of the North American Menopause Society.19(7):836-837[DOI] 10.1097/gme.0b013e31825b32ea.[PMID] .PubMed·Publisher's Site2012The Levonorgestrel-Releasing Intrauterine System in Heavy Menstrual Bleeding a Benefit-Risk Review.72():193-215[DOI] .[PMID] .PubMed·Publisher's Site2012The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.Drugs.72(2):193-215[DOI] 10.2165/11598960-000000000-00000.[PMID] 22268392.46 citations·PubMed·Publisher's Site2012Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.Menopause (New York, N.Y.).19(6):602-3[DOI] 10.1097/gme.0b013e31824c8a5a.[PMID] 22549171.9 citations·PubMed·Publisher's Site2011Incidental diagnosis of appendiceal mucocele with vaginal ultrasonography and computed tomography.Obstetrics and gynecology.117(2 Pt 2):479-481[DOI] 10.1097/AOG.0b013e318203ea37.[PMID] 21252796.4 citations·PubMed·Publisher's Site2011Removing the black box warning for depot medroxyprogesterone acetate.Contraception.84(3):212-3[DOI] 10.1016/j.contraception.2011.01.009.[PMID] 21843682.17 citations·PubMed·Publisher's Site2011Update on hormonal contraception and bone density.Reviews in endocrine & metabolic disorders.12(2):93-106[DOI] 10.1007/s11154-011-9180-6.[PMID] 21559817.44 citations·PubMed·Publisher's Site2010Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill: a Randomized Controlled Trial ReplyObstetrics and Gynecology.115(4):867-868[DOI] 10.1097/AOG.0b013e3181d7047e.[PMID] .PubMed·Publisher's Site2010Depot medroxyprogesterone acetate contraceptive injections and skeletal health.Women's health (London, England).6(3):339-42[DOI] 10.2217/whe.10.17.[PMID] 20426597.7 citations·PubMed·Publisher's Site2010Levonorgestrel-Releasing Intrauterine System Or Medroxyprogesterone for Heavy Menstrual Bleeding: a Randomized Controlled Trial ReplyObstetrics and Gynecology.116(6):1456-[DOI] 10.1097/AOG.0b013e3181ff7331.[PMID] .PubMed·Publisher's Site2010Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial.Obstetrics and gynecology.116(3):625-632[DOI] 10.1097/AOG.0b013e3181ec622b.[PMID] 20733445.99 citations·PubMed·Publisher's Site2010The Oncogenic Potential of Endometrial Polyps: a Systematic Review and Meta-AnalysisMenopause-the Journal of the North American Menopause Society.17():1233-[DOI] .[PMID] .PubMed·Publisher's Site2010The oncogenic potential of endometrial polyps: a systematic review and meta-analysis.Obstetrics and gynecology.116(5):1197-205[DOI] 10.1097/AOG.0b013e3181f74864.[PMID] 20966706.132 citations·PubMed·Publisher's Site2009Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.Contraception.79(5):350-5[DOI] 10.1016/j.contraception.2008.11.011.[PMID] 19341846.29 citations·PubMed·Publisher's Site2009An evidence-based approach to postpartum use of depot medroxyprogesterone acetate in breastfeeding women.Contraception.80(1):4-6[DOI] 10.1016/j.contraception.2008.12.014.[PMID] 19501209.12 citations·PubMed·Publisher's Site2009Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial.Obstetrics and gynecology.114(6):1205-1212[DOI] 10.1097/AOG.0b013e3181beab47.[PMID] 19935020.21 citations·PubMed·Publisher's Site2009Depo-Provera and skeletal health: reviewing the evidence; developing and disseminating a consensus.Contraception.79(3):165-6[DOI] 10.1016/j.contraception.2008.06.017.[PMID] 19185667.2 citations·PubMed·Publisher's Site2009Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and metaanalysis.American journal of obstetrics and gynecology.201(1):107.e1-6[DOI] 10.1016/j.ajog.2009.03.021.[PMID] 19398089.91 citations·PubMed·Publisher's Site2009Effective herbal treatment of vasomotor symptoms--are we any closer?Menopause (New York, N.Y.).16(3):428-9[DOI] 10.1097/gme.0b013e31819774e4.[PMID] 19169160.PubMed·Publisher's Site2009Ethics and referral for abortion.American journal of obstetrics and gynecology.200(6):e9; author reply e9-10[DOI] 10.1016/j.ajog.2008.12.017.[PMID] 19286151.4 citations·PubMed·Publisher's Site2009Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis.Obstetrics and gynecology.114(3):631-640[DOI] 10.1097/AOG.0b013e3181b47217.[PMID] 19701045.75 citations·PubMed·Publisher's Site2009Levonorgestrel Intrauterine System and Medroxyprogesterone Acetate for Treatment of Heavy Menstrual BleedingContraception.80():212-[DOI] .[PMID] .PubMed·Publisher's Site2009Levonorgestrel-Releasing Intrauterine System and Endometrial Ablation in Heavy Menstrual Bleeding a Systematic Review and Meta-AnalysisObstetrics and Gynecology.113():1104-1116[DOI] .[PMID] .PubMed·Publisher's Site2009Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis.Obstetrics and gynecology.113(5):1104-1116[DOI] 10.1097/AOG.0b013e3181a1d3ce.[PMID] 19384127.81 citations·PubMed·Publisher's Site2009Postmenopausal osteoporosis: fracture risk and prevention.The Journal of family practice.58(11 Suppl Postmenopausal):S1-6[DOI] .[PMID] 19891943.14 citations·PubMed·Publisher's Site2009Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.Fertility and sterility.91(5):1646-53[DOI] 10.1016/j.fertnstert.2008.02.140.[PMID] 18423453.125 citations·PubMed·Publisher's Site2009Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.Contraception.80(1):7-17[DOI] 10.1016/j.contraception.2009.02.005.[PMID] 19501210.73 citations·PubMed·Publisher's Site2009The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health.Contraception.79(3):167-77[DOI] 10.1016/j.contraception.2008.10.016.[PMID] 19185668.27 citations·PubMed·Publisher's Site2009Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.Menopause (New York, N.Y.).16(4):735-41[DOI] 10.1097/gme.0b013e318199e734.[PMID] 19252451.42 citations·PubMed·Publisher's Site2009Use of hormonal contraception in adolescents: skeletal health issues.Current opinion in obstetrics & gynecology.21(5):396-401[DOI] 10.1097/GCO.0b013e32832c9cc6.[PMID] 19491681.9 citations·PubMed·Publisher's Site2008Bone density recovery after depot medroxyprogesterone acetate injectable contraception use.Contraception.77(2):67-76[DOI] 10.1016/j.contraception.2007.10.005.[PMID] 18226668.83 citations·PubMed·Publisher's Site2008Clinical practice. Hormonal contraception in women of older reproductive age.The New England journal of medicine.358(12):1262-70[DOI] 10.1056/NEJMcp0708481.[PMID] 18354104.48 citations·PubMed·Publisher's Site2008Depo-Provera and skeletal health: a survey of Florida obstetrics and gynecologist physicians.Contraception.78(5):370-6[DOI] 10.1016/j.contraception.2008.07.022.[PMID] 18929733.16 citations·PubMed·Publisher's Site2008Depot Medroxyprogesterone Acetate and Skeletal Health: a Survey of Florida Ob/Gyn PhysiciansContraception.78(2):173-[DOI] 10.1016/j.contraception.2008.04.032.[PMID] .PubMed·Publisher's Site2008Do mechanical methods of cervical ripening increase infectious morbidity? A systematic review.American journal of obstetrics and gynecology.199(2):177-87; discussion 187[DOI] 10.1016/j.ajog.2008.05.005.[PMID] 18674661.83 citations·PubMed·Publisher's Site2008Metaanalysis of Diagnostic and Prognostic Studies: the Challenge Continues - ReplyAmerican Journal of Obstetrics and Gynecology.199(1):E16-E17[DOI] 10.1016/j.ajog.2008.02.040.[PMID] .PubMed·Publisher's Site2007Aromatase inhibitor therapy for uterine bleeding in a postmenopausal woman with leiomyomata.Menopause (New York, N.Y.).14(5):941-3[DOI] .[PMID] 17667148.8 citations·PubMed·Publisher's Site2007Cervical length and the risk of spontaneous labor at term.Journal of perinatology : official journal of the California Perinatal Association.27(12):749-53[DOI] .[PMID] 17762846.8 citations·PubMed·Publisher's Site2007Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perception.Contraception.75(1):4-10[DOI] .[PMID] 17161116.34 citations·PubMed·Publisher's Site2007Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.Obstetrics and gynecology.110(3):577-86[DOI] .[PMID] 17766603.50 citations·PubMed·Publisher's Site2007Long-acting contraceptives in adolescents.Current opinion in obstetrics & gynecology.19(5):453-60[DOI] .[PMID] 17885461.25 citations·PubMed·Publisher's Site2007Long-acting hormonal contraceptives--indispensable in preventing teen pregnancy.The Journal of adolescent health : official publication of the Society for Adolescent Medicine.40(1):1-3[DOI] .[PMID] 17185200.16 citations·PubMed·Publisher's Site2007Pharmacy access to emergency hormonal contraception in Jacksonville, FL: a secret shopper survey.Contraception.75(2):126-30[DOI] .[PMID] 17241842.25 citations·PubMed·Publisher's Site2007Progestin-releasing intrauterine systems and leiomyoma.Contraception.75(6 Suppl):S130-3[DOI] .[PMID] 17531604.36 citations·PubMed·Publisher's Site2007Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials.Contraception.75(1):11-5[DOI] .[PMID] 17161117.63 citations·PubMed·Publisher's Site2007Sonographic cervical assessment to predict the success of labor induction: a systematic review with metaanalysis.American journal of obstetrics and gynecology.197(2):186-92[DOI] .[PMID] 17689645.56 citations·PubMed·Publisher's Site2007Use of the levonorgestrel-IUD in the treatment of menorrhagia: improving patient outcomes while reducing the need for surgical management.Managed care interface.20(3):47-50[DOI] .[PMID] 17458481.1 citations·PubMed·Publisher's Site2006Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.Contraception.74(2):90-9[DOI] .[PMID] 16860045.70 citations·PubMed·Publisher's Site2006Depot medroxyprogesterone acetate and bone mineral density in adolescents--the Black Box Warning: a Position Paper of the Society for Adolescent Medicine.The Journal of adolescent health : official publication of the Society for Adolescent Medicine.39(2):296-301[DOI] .[PMID] 16857545.92 citations·PubMed·Publisher's Site2006Hormone therapy and breast cancer risk: trumping fear with facts.Menopause (New York, N.Y.).13(2):160-3[DOI] .[PMID] 16645526.4 citations·PubMed·Publisher's Site2005Assessing the neonatal safety of indomethacin tocolysis: a systematic review with meta-analysis.Obstetrics and gynecology.106(1):173-9[DOI] .[PMID] 15994634.70 citations·PubMed·Publisher's Site2005Beyond the pill: new data and options in hormonal and intrauterine contraception.American journal of obstetrics and gynecology.192(4):998-1004[DOI] .[PMID] 15846172.16 citations·PubMed·Publisher's Site2005Contraceptive equity and access in the United States: a 2005 update.Contraception.71(5):317-8[DOI] .[PMID] 15854629.4 citations·PubMed·Publisher's Site2005Depo-Provera's black box: time to reconsider?Contraception.72(3):165-7[DOI] .[PMID] 16102548.24 citations·PubMed·Publisher's Site2005Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.Obstetrics and gynecology.105(6):1389-96[DOI] .[PMID] 15932834.66 citations·PubMed·Publisher's Site2005Maternal death caused by midgut volvulus after bariatric surgery.American journal of obstetrics and gynecology.193(5):1748-9[DOI] .[PMID] 16260222.37 citations·PubMed·Publisher's Site2005Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.Obstetrics and gynecology.105(2):273-9[DOI] .[PMID] 15684151.113 citations·PubMed·Publisher's Site2005Sublingual misoprostol for labor induction: a randomized clinical trial.Obstetrics and gynecology.105(2):365-71[DOI] .[PMID] 15684166.13 citations·PubMed·Publisher's Site2004Contraceptive efficacy and safety of DMPA-SC.Contraception.70(4):269-75[DOI] .[PMID] 15451329.113 citations·PubMed·Publisher's Site2004Enhancing oral contraceptive success: the potential of new formulations.American journal of obstetrics and gynecology.190(4 Suppl):S23-9[DOI] .[PMID] 15105795.9 citations·PubMed·Publisher's Site2004Randomized trial to compare perioperative outcomes of Filshie clip vs. Pomeroy technique for postpartum and intraoperative cesarean tubal sterilization: a pilot study.Contraception.69(4):267-70[DOI] .[PMID] 15033399.14 citations·PubMed·Publisher's Site2004Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives.Contraception.70(5):359-63[DOI] .[PMID] 15504373.82 citations·PubMed·Publisher's Site2003Clinical characteristics of patients with an abnormal clomiphene citrate challenge test.American journal of obstetrics and gynecology.189(2):348-52; discussion 352[DOI] .[PMID] 14520190.2 citations·PubMed·Publisher's Site2003Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.JAMA.290(13):1739-48[DOI] .[PMID] 14519708.347 citations·PubMed·Publisher's Site2003Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.83(2):151-7[DOI] .[PMID] 14550589.16 citations·PubMed·Publisher's Site2003Labor induction versus expectant management for postterm pregnancies: a systematic review with meta-analysis.Obstetrics and gynecology.101(6):1312-8[DOI] .[PMID] 12798542.114 citations·PubMed·Publisher's Site2003Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.Circulation.107(9):e67-8; author reply e67[DOI] .[PMID] 12628963.2 citations·PubMed·Publisher's Site2003Misoprostol use during the third stage of labor.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.82(2):143-52[DOI] .[PMID] 12873774.29 citations·PubMed·Publisher's Site2002Clinical manifestations of rotavirus infection in the neonatal intensive care unit.The Pediatric infectious disease journal.21(12):1099-105[DOI] .[PMID] 12488657.51 citations·PubMed·Publisher's Site2002Expectant management versus labor induction for suspected fetal macrosomia: a systematic review.Obstetrics and gynecology.100(5 Pt 1):997-1002[DOI] .[PMID] 12423867.76 citations·PubMed·Publisher's Site2002Gynecologic problems of the perimenopause: evaluation and treatment.Obstetrics and gynecology clinics of North America.29(3):455-73[DOI] .[PMID] 12353668.3 citations·PubMed·Publisher's Site2002Labor induction with 25 microg versus 50 microg intravaginal misoprostol: a systematic review.Obstetrics and gynecology.99(1):145-51[DOI] .[PMID] 11777525.48 citations·PubMed·Publisher's Site2002Noncontraceptive health benefits of oral contraceptives.Reviews in endocrine & metabolic disorders.3(3):277-83[DOI] .[PMID] 12215722.6 citations·PubMed·Publisher's Site2002The effect of tablet moistening on labor induction with intravaginal misoprostol: a randomized trial.Obstetrics and gynecology.99(6):1080-4[DOI] .[PMID] 12052603.14 citations·PubMed·Publisher's Site2002Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.Medscape women's health.7(4):8-[DOI] .[PMID] 12466740.6 citations·PubMed·Publisher's Site2001Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: a randomized controlled trial.Obstetrics and gynecology.98(5 Pt 1):745-50[DOI] .[PMID] 11704163.31 citations·PubMed·Publisher's Site2001Current options for injectable contraception in the United States.Seminars in reproductive medicine.19(4):331-7[DOI] .[PMID] 11727175.6 citations·PubMed·Publisher's Site2001Lunelle monthly injectable contraceptive. An effective, safe, and convenient new birth control option.Archives of gynecology and obstetrics.265(3):119-23[DOI] .[PMID] 11561738.10 citations·PubMed·Publisher's Site2001Outpatient cervical ripening with intravaginal misoprostol.Obstetrics and gynecology.97(2):325-6[DOI] .[PMID] 11271511.3 citations·PubMed·Publisher's Site2001Route of breech delivery and maternal and neonatal outcomes.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.73(1):7-14[DOI] .[PMID] 11336715.24 citations·PubMed·Publisher's Site2001The hormone continuum: accrual of women's health benefits.International journal of fertility and women's medicine.46(2):60-72[DOI] .[PMID] 11374657.2 citations·PubMed·Publisher's Site2000Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives.Contraception.62(6):289-95[DOI] .[PMID] 11239615.18 citations·PubMed·Publisher's Site2000Cervical ripening and labor induction after previous cesarean delivery.Clinical obstetrics and gynecology.43(3):513-23[DOI] .[PMID] 10949755.41 citations·PubMed·Publisher's Site2000Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial.Contraception.61(5):295-302[DOI] .[PMID] 10906499.32 citations·PubMed·Publisher's Site2000Injectable contraception. New and existing options.Obstetrics and gynecology clinics of North America.27(4):741-80[DOI] .[PMID] 11091987.47 citations·PubMed·Publisher's Site2000Menstruation: choosing whether...and when.Contraception.62(6):277-84[DOI] .[PMID] 11239613.75 citations·PubMed·Publisher's Site2000Misoprostol for cervical ripening and labor induction: a systematic review of the literature.Clinical obstetrics and gynecology.43(3):475-88[DOI] .[PMID] 10949752.67 citations·PubMed·Publisher's Site2000Perinatal morbidity associated with misoprostol-induced labor.American journal of obstetrics and gynecology.182(3):749-50[DOI] .[PMID] 10739550.PubMed·Publisher's Site2000Prophylactic amnioinfusion for intrapartum oligohydramnios: a meta-analysis of randomized controlled trials.Obstetrics and gynecology.96(5 Pt 2):861-6[DOI] .[PMID] 11094242.12 citations·PubMed·Publisher's Site2000The effect of obstetric resident gender on forceps delivery rate.American journal of obstetrics and gynecology.182(5):1050-1[DOI] .[PMID] 10819824.11 citations·PubMed·Publisher's Site2000Uterine rupture associated with the use of prostaglandin E1 in patients with previous cesarean delivery.American journal of obstetrics and gynecology.182(4):990-1[DOI] .[PMID] 10764490.6 citations·PubMed·Publisher's Site1999Cervical ripening and labor induction with a controlled-release dinoprostone vaginal insert: a meta-analysis.Obstetrics and gynecology.94(5 Pt 2):878-83[DOI] .[PMID] 10546777.25 citations·PubMed·Publisher's Site1999Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group.Contraception.60(4):179-87[DOI] .[PMID] 10640164.58 citations·PubMed·Publisher's Site1999Efficacy of maintenance therapy after acute tocolysis: a meta-analysis.American journal of obstetrics and gynecology.181(2):484-90[DOI] .[PMID] 10454704.58 citations·PubMed·Publisher's Site1999Long-acting hormonal contraception: assessing impact on bone density, weight, and mood.International journal of fertility and women's medicine.44(2):110-7[DOI] .[PMID] 10338269.13 citations·PubMed·Publisher's Site1999Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): a contraceptive method for women in the US and worldwide.Contraception.60(4):177-8[DOI] .[PMID] 10640163.6 citations·PubMed·Publisher's Site1999Oral contraceptive health benefits: perception versus reality.Contraception.59(1 Suppl):29S-33S[DOI] .[PMID] 10342094.34 citations·PubMed·Publisher's Site1998Cesarean scar pregnancy: imaging and treatment with conservative surgery.Obstetrics and gynecology.91(5 Pt 2):838-40[DOI] .[PMID] 9572183.55 citations·PubMed·Publisher's Site1998Devices for endometrial sampling. A comparison.The Journal of reproductive medicine.43(3):180-4[DOI] .[PMID] 9564641.9 citations·PubMed·Publisher's Site1998Infertility. A clinical guide for the internist.The Medical clinics of North America.82(2):271-95[DOI] .[PMID] 9531926.3 citations·PubMed·Publisher's Site1998Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians.International journal of fertility and women's medicine.43(2):73-83[DOI] .[PMID] 9609206.56 citations·PubMed·Publisher's Site1998Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial.Obstetrics and gynecology.91(3):401-5[DOI] .[PMID] 9491868.79 citations·PubMed·Publisher's Site1998Oral contraceptive estrogen dose considerations.Contraception.58(3 Suppl):15S-21S; quiz 66S[DOI] .[PMID] 9807688.21 citations·PubMed·Publisher's Site1997Contraception for the adolescent patient.International journal of fertility and women's medicine.42(1):30-8[DOI] .[PMID] 9113833.6 citations·PubMed·Publisher's Site1997Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study.Obstetrics and gynecology.89(6):909-12[DOI] .[PMID] 9170463.48 citations·PubMed·Publisher's Site1997Misoprostol for cervical ripening and labor induction: a meta-analysis.Obstetrics and gynecology.89(4):633-42[DOI] .[PMID] 9083326.169 citations·PubMed·Publisher's Site1997Oral administration of misoprostol for labor induction: a randomized controlled trial.Obstetrics and gynecology.90(1):153-4[DOI] .[PMID] 9207832.2 citations·PubMed·Publisher's Site1997Randomized trial of two doses of the prostaglandin E1 analog misoprostol for labor induction.American journal of obstetrics and gynecology.177(2):364-9; discussion 369[DOI] .[PMID] 9290452.56 citations·PubMed·Publisher's Site1997Reappearance of the intrauterine device: a 'user-friendly' contraceptive.International journal of fertility and women's medicine.42(2):120-7[DOI] .[PMID] 9160223.8 citations·PubMed·Publisher's Site1997The role of androgens in menopausal hormonal replacement.Endocrinology and metabolism clinics of North America.26(2):391-7[DOI] .[PMID] 9193891.8 citations·PubMed·Publisher's Site1996Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.The Journal of reproductive medicine.41(5 Suppl):419-27[DOI] .[PMID] 8725705.30 citations·PubMed·Publisher's Site1996Long-acting contraceptive options.International journal of fertility and menopausal studies.41(2):69-76[DOI] .[PMID] 8829701.17 citations·PubMed·Publisher's Site1996Randomized trial of oxytocin alone and with propranolol in the management of dysfunctional labor.Obstetrics and gynecology.88(4 Pt 1):517-20[DOI] .[PMID] 8841209.19 citations·PubMed·Publisher's Site1995A trial of labor complicated by uterine rupture following amnioinfusion.Southern medical journal.88(8):847-8[DOI] .[PMID] 7631213.6 citations·PubMed·Publisher's Site1995Calcium supplementation in mild preeclampsia remote from term: a randomized double-blind clinical trial.Obstetrics and gynecology.85(6):915-8[DOI] .[PMID] 7770260.22 citations·PubMed·Publisher's Site1995Contraception. A clinical review for the internist.The Medical clinics of North America.79(6):1377-409[DOI] .[PMID] 7475496.6 citations·PubMed·Publisher's Site1995Labor induction in patients with previous cesarean section.American journal of perinatology.12(6):450-4[DOI] .[PMID] 8579661.10 citations·PubMed·Publisher's Site1995Preinduction cervical ripening with commercially available prostaglandin E2 gel: a randomized, double-blind comparison with a hospital-compounded preparation.American journal of obstetrics and gynecology.173(4):1079-84[DOI] .[PMID] 7485297.14 citations·PubMed·Publisher's Site1995Pyelonephritis in pregnancy: once-a-day ceftriaxone versus multiple doses of cefazolin. A randomized, double-blind trial.American journal of obstetrics and gynecology.172(1 Pt 1):129-33[DOI] .[PMID] 7847521.26 citations·PubMed·Publisher's Site1994Cesarean section rates in teaching hospitals: a national survey.Birth (Berkeley, Calif.).21(4):194-6[DOI] .[PMID] 7857465.10 citations·PubMed·Publisher's Site1994Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents.Obstetrics and gynecology.83(5 Pt 1):799-801[DOI] .[PMID] 8164948.1 citations·PubMed·Publisher's Site1994Long-acting injectable contraception with depot medroxyprogesterone acetate.American journal of obstetrics and gynecology.170(5 Pt 2):1543-9[DOI] .[PMID] 8178904.77 citations·PubMed·Publisher's Site1994Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients.Obstetrics and gynecology.84(3):349-53[DOI] .[PMID] 8058229.82 citations·PubMed·Publisher's Site1994Resident research in obstetrics and gynecology.The Journal of reproductive medicine.39(8):635-8[DOI] .[PMID] 7996529.9 citations·PubMed·Publisher's Site1993Combined oral contraception with desogestrel/ethinyl estradiol: tolerability profile.American journal of obstetrics and gynecology.168(3 Pt 2):1028-33[DOI] .[PMID] 8447356.13 citations·PubMed·Publisher's Site1993Injectable contraception with depot medroxyprogesterone acetate. Current status.Drugs.45(6):857-865[DOI] 10.2165/00003495-199345060-00001.[PMID] 7691495.16 citations·PubMed·Publisher's Site1993Labor induction with the prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial.Obstetrics and gynecology.81(3):332-6[DOI] .[PMID] 8437780.142 citations·PubMed·Publisher's Site1992Detection of cervical Chlamydia trachomatis and Neisseria gonorrhoeae with deoxyribonucleic acid probe assays in obstetric patients.American journal of obstetrics and gynecology.167(3):588-91[DOI] .[PMID] 1530008.18 citations·PubMed·Publisher's Site1992Hygroscopic cervical dilators and prostaglandin E2 gel for preinduction cervical ripening. A randomized, prospective comparison.The Journal of reproductive medicine.37(4):355-9[DOI] .[PMID] 1593561.33 citations·PubMed·Publisher's Site1992Oral contraceptives and gynecologic cancer: an update for the 1990s.American journal of obstetrics and gynecology.167(4 Pt 2):1171-6[DOI] .[PMID] 1415442.13 citations·PubMed·Publisher's Site1991Calcium excretion in preeclampsia.Obstetrics and gynecology.77(4):510-3[DOI] .[PMID] 2002971.39 citations·PubMed·Publisher's Site1990Pseudotumor cerebri following eclampsia.European neurology.30(1):6-8[DOI] .[PMID] 2298229.1 citations·PubMed·Publisher's Site1990Reducing cesarean sections at a teaching hospital.American journal of obstetrics and gynecology.163(3):1081-7; discussion 1087[DOI] .[PMID] 2403133.54 citations·PubMed·Publisher's Site1989Injectable contraception.Clinical obstetrics and gynecology.32(2):356-68[DOI] .[PMID] 2525977.17 citations·PubMed·Publisher's Site1988Comparison of endometrial biopsy with the endometrial Pipelle and Vabra aspirator.The Journal of reproductive medicine.33(5):427-31[DOI] .[PMID] 3385697.91 citations·PubMed·Publisher's Site1988Successful pregnancy after previous conservative treatment of an advanced cervical pregnancy.Obstetrics and gynecology.71(6 Pt 2):1023-5[DOI] .[PMID] 3287250.36 citations·PubMed·Publisher's Site1987A physician's guide to adoption.JAMA.258(24):3537-41[DOI] .[PMID] 3316728.9 citations·PubMed·Publisher's Site1987Prenatal care and HIV screening.JAMA.258(19):2693-4[DOI] .[PMID] 3669236.21 citations·PubMed·Publisher's Site1986Maternal mortality in women aged 35 years or older: United States.JAMA.255(1):53-7[DOI] .[PMID] 3940305.45 citations·PubMed·Publisher's Site1986Mental retardation: a controversial indication for hysterectomy.Obstetrics and gynecology.68(3):436-8[DOI] .[PMID] 3737068.13 citations·PubMed·Publisher's Site1985Abortions that fail.Obstetrics and gynecology.66(4):533-7[DOI] .[PMID] 4047543.57 citations·PubMed·Publisher's Site1985Causes of maternal mortality in the United States.Obstetrics and gynecology.65(5):605-12[DOI] .[PMID] 3982738.266 citations·PubMed·Publisher's Site1984Maternal deaths in the United States by size of hospital.Obstetrics and gynecology.64(3):311-4[DOI] .[PMID] 6462559.13 citations·PubMed·Publisher's Site1984Maternal mortality surveillance, 1974-1978.MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.33(1):5SS-8SS[DOI] .[PMID] 6433176.1 citations·PubMed·Publisher's Site1984Outcome of out-of-hospital births should not be measured by birth weight.Public health reports (Washington, D.C. : 1974).99(5):435-436[DOI] .[PMID] 19313434.PubMed·Publisher's Site1984Perinatal and maternal mortality in a religious group avoiding obstetric care.American journal of obstetrics and gynecology.150(7):826-31[DOI] .[PMID] 6507508.80 citations·PubMed·Publisher's Site1984Progestogens, estrogen therapy, and endometrial cancer.Annals of internal medicine.100(2):316-[DOI] .[PMID] 6691683.1 citations·PubMed·Publisher's Site1984The Faith Assembly: a study of perinatal and maternal mortality.Indiana medicine : the journal of the Indiana State Medical Association.77(3):180-3[DOI] .[PMID] 6707460.7 citations·PubMed·Publisher's Site1983Abortion surveillance, 1979-1980.MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.32(2):1SS-7SS[DOI] .[PMID] 6621605.PubMed·Publisher's Site1982Point of law: what are the legal implications of prescribing and administering FDA-approved drugs in nonapproved ways?The Hospital medical staff.11(2):15-8[DOI] .[PMID] 10254209.PubMed·Publisher's Site1980Estrogen use in postmenopausal women.The New England journal of medicine.303(25):1477-8[DOI] .[PMID] 7432409.1 citations·PubMed·Publisher's Site1979Needle tract endometriosis: an unusual complication of amniocentesis.Obstetrics and gynecology.54(6):753-5[DOI] .[PMID] 160025.49 citations·PubMed·Publisher's Site Show More Office Information Academic Office 3rd Floor, LRC653-1 West 8th Street, L17Jacksonville, FL 32209(904) 244-3109 andrew.kaunitz@jax.ufl.edu Senior Medical Secretary Kobe Harrell(904) 244-3109kobe.harrell@jax.ufl.edu Show More Clinical Research A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety Education Medical Degree1978 · Columbia University College of Physicians And Surgeons, New York, NY, USAObstetrics and Gynecology Residency1982 · Northwestern Memorial Hospital, Chicago, IL, USA Show More News September 10, 2018 Obstetrics and gynecology to undergo leadership changes June 14, 2018 Faculty members recognized for milestone service at UF COMJ December 19, 2017 When you’re last on your own to-do list October 16, 2015 What Everyone Should Know About Breast Health 2015 August 15, 2014 Kaunitz continues research efforts following receipt of prestigious UF accolade Media Coverage January 31, 2020 Screening Mammograms: Is AI Better Than a Radiologist? Medscape December 3, 2019 Predicting Endometrial Ablation Failure Medscape June 7, 2019 Not All "Vaginal Itching" is the Same (But It's All Miserable) Medscape November 29, 2016 Should there really be a cutoff age for mammograms? CNN August 23, 2014 Uterine fibriods study News4Jax (WJXT)